Summary

Middle East orthopedic devices Market Summary

The Middle East orthopedic devices market size was estimated at USD 1.96 billion in 2024 and is projected to reach USD 3.00 billion by 2033, growing at a CAGR of 4.69% from 2025 to 2033. The increasing incidence of road accident injuries drives market growth.

According to the article published in the SAUDIGAZETTE in July 2024, in Saudi Arabia, the rate of accident-related injuries has been recorded at nearly 70.9 cases per 100,000 people, reflecting the high prevalence of trauma cases that require surgical intervention. Moreover, as per the Al Arabiya Network article, in 2023, the UAE recorded 5,568 individuals injured in road incidents, a 10% increase from 2022.

These incidents often result in fractures, joint damage, and other musculoskeletal complications, thereby driving the need for advanced orthopedic implants, trauma fixation systems, and rehabilitation solutions. Rising musculoskeletal disorders drive market growth. According to an NCBI article published in March 2023, in Saudi Arabia, musculoskeletal disorders are becoming a significant public health concern, with osteoarthritis emerging as one of the most common conditions. A population-based study reported that knee osteoarthritis affected nearly one-fifth of the population (18.9%), with women experiencing a higher prevalence (20.3%) compared to men (13.1%). The study highlighted age, obesity, gender, and previous joint injuries as key risk factors contributing to the condition. This rising burden of degenerative joint diseases is expected to accelerate demand for advanced orthopedic devices in the Middle East, particularly in joint replacement, minimally invasive surgical tools, and supportive rehabilitation technologies. While the population ages and lifestyle-related risk factors persist, the need for orthopedic interventions in Saudi Arabia and the wider region is projected to grow steadily.

Middle East Orthopedic Devices Market Report Segmentation

This report forecasts revenue growth at country levels and analyzes the industry trends in each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the Middle East orthopedic devices market report based on product, end-use, and country:

• Product Outlook (Revenue USD Million, 2021 - 2033)
• Joint Replacement/ Orthopedic Implants
o Lower Extremity Implants
o Knee Implants
o Hip Implants
o Foot & Ankle Implants
o Spinal Implants
o Dental
o Dental Implants
o Craniomaxillofacial Implants
o Upper Extremity Implants
o Elbow Implants
o Hand & Wrist Implants
o Shoulder Implants
• Trauma
o Implants
o Accessories (Plates, Screws, Nails, Pins, Wires)
o Instruments
• Sports Medicine
o Body Reconstruction & Repair
o Accessories
o Body Monitoring & Evaluation
o Body Support & Recovery
• Orthobiologics
o Viscosupplementation
o Demineralized Bone Matrix
o Synthetic Bone Substitutes
o Bone Morphogenetic Protein (BMP)
o Stem Cell Therapy
o Allograft
• Others
• End-use Outlook (Revenue USD Million, 2021 - 2033)
• Hospitals
• Outpatient Facilities
• Country Outlook Revenue USD Million, 2021 - 2033)
• ME
o Saudi Arabia
o UAE
o Kuwait
o Qatar
o Oman  

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Orthopedic Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising accident incidence
3.2.1.2. Rising orthopedic disorders
3.2.1.3. Growing aging population
3.2.1.4. Increasing musculoskeletal disorders caused by sedentary routines and obesity
3.2.2. Market restraint analysis
3.2.2.1. High cost of implants and surgical procedures
3.2.2.2. Reimbursement and regulatory hurdles
3.3. Orthopedic devices: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
3.4. Orthopedic Devices Market: Technology Trend Analysis
3.5. Orthopedic Disease Prevalence
3.6. Impact of COVID-19 Pandemic on Orthopedic Devices Market
3.7. Regulatory and Political Forces
Chapter 4. Orthopedic Devices Market Segment Analysis, By Product, 2021 - 2033 (USD Million)
4.1. Definition and Scope
4.2. Product Market Share Analysis, 2024 & 2033
4.3. Segment Dashboard
4.4. Middle East Orthopedic Devices Market, by Product, 2021 - 2033
4.5. Joint Replacement/ Orthopedic Implants
4.5.1. Joint Replacement/ Orthopedic Implants market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.2. Lower Extremity Implants
4.5.2.1. Lower Extremity Implants market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.2.2. Knee Implants
4.5.2.2.1. Knee Implants market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.2.3. Hip Implants
4.5.2.3.1. Hip Implants market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.2.4. Foot & Ankle Implants
4.5.2.4.1. Foot & Ankle Implants market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.3. Spinal Implants
4.5.3.1. Spinal Implants market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.4. Dental
4.5.4.1. Dental market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.4.2. Dental Implants
4.5.4.2.1. Dental implants market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.4.3. Craniomaxillofacial Implants
4.5.4.3.1. Craniomaxillofacial Implants market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.5. Upper Extremity Implants
4.5.5.1. Upper Extremity Implants market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.5.2. Elbow Implants
4.5.5.2.1. Elbow Implants market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.5.3. Hand & Wrist Implants
4.5.5.3.1. Hand & Wrist Implants market estimates and forecasts, 2021 - 2033 (USD Million)
4.5.5.4. Shoulder Implants
4.5.5.4.1. Shoulder Implants market estimates and forecasts, 2021 - 2033 (USD Million)
4.6. Trauma
4.6.1. Trauma market estimates and forecasts, 2021 - 2033 (USD Million)
4.6.2. Implants
4.6.2.1. Implants market estimates and forecasts, 2021 - 2033 (USD Million)
4.6.3. Accessories
4.6.3.1. Accessories market estimates and forecasts, 2021 - 2033 (USD Million)
4.6.4. Instruments
4.6.4.1. Instruments market estimates and forecasts, 2021 - 2033 (USD Million)
4.7. Sports Medicine
4.7.1. Sports Medicine market estimates and forecasts, 2021 - 2033 (USD Million)
4.7.2. Body Reconstruction & Repair
4.7.2.1. Body Reconstruction & Repair market estimates and forecasts, 2021 - 2033 (USD Million)
4.7.3. Accessories
4.7.3.1. Accessories market estimates and forecasts, 2021 - 2033 (USD Million)
4.7.4. Body Monitoring & Evaluation
4.7.4.1. Body Monitoring & Evaluation market estimates and forecasts, 2021 - 2033 (USD Million)
4.7.5. Body Support & Recovery
4.7.5.1. Body Support & Recovery market estimates and forecasts, 2021 - 2033 (USD Million)
4.8. Orthobiologics
4.8.1. Orthobiologics market estimates and forecasts, 2021 - 2033 (USD Million)
4.8.2. Viscosupplementation
4.8.2.1. Viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
4.8.3. Demineralized Bone Matrix
4.8.3.1. Demineralized Bone Matrix market estimates and forecasts, 2021 - 2033 (USD Million)
4.8.4. Synthetic Bone Substitutes
4.8.4.1. Synthetic Bone Substitutes market estimates and forecasts, 2021 - 2033 (USD Million)
4.8.5. Bone Morphogenetic Protein (BMP)
4.8.5.1. Bone Morphogenetic Protein (BMP) market estimates and forecasts, 2021 - 2033 (USD Million)
4.8.6. Stem Cell Therapy
4.8.6.1. Stem Cell Therapy market estimates and forecasts, 2021 - 2033 (USD Million)
4.8.7. Allograft
4.8.7.1. Allograft market estimates and forecasts, 2021 - 2033 (USD Million)
4.9. Other
4.9.1. Other market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. Orthopedic Devices Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)
5.1. Definition and Scope
5.2. End Use Market Share Analysis, 2024 & 2033
5.3. Segment Dashboard
5.4. ME Orthopedic devices Market, by end use, 2021 - 2033
5.5. Hospitals
5.5.1. Hospitals market estimates and forecasts, 2021 - 2033 (USD million)
5.6. Outpatient facilities
5.6.1. Outpatient facilities market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. Orthopedic Devices Market Segment Analysis, By Region, By Product, By End Use, 2021 - 2033 (USD Million)
6.1. Regional Market Share Analysis, 2024 & 2033
6.2. Regional Market Dashboard
6.3. Regional Market Snapshot
6.4. Orthopedic Devices Market Share by Region, 2024 & 2033:
6.5. MEA
6.5.1. Saudi Arabia
6.5.1.1. Saudi Arabia orthopedic devices market, 2021 - 2033 (USD Million)
6.5.2. UAE
6.5.2.1. UAE orthopedic devices market, 2021 - 2033 (USD Million)
6.5.3. Kuwait
6.5.3.1. Kuwait orthopedic devices market, 2021 - 2033 (USD Million)
6.5.4. Qatar
6.5.4.1. Qatar orthopedic devices market, 2021 - 2033 (USD Million)
6.5.5. Oman
6.5.5.1. Oman orthopedic devices market, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Categorization
7.3. Company Profiles
7.3.1. Medtronic
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Stryker
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. Zimmer Biomet
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. DePuy Synthes
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Smith+Nephew
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Aesculap, Inc. - a B. Braun company
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. CONMED Corporation
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. NuVasive, Inc. (merged with Globus Medical)
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Enovis (formerly known as DJO)
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives